Selective serotonin reuptake inhibitors and adverse effects: a narrative review

AN Edinoff, HA Akuly, TA Hanna, CO Ochoa… - Neurology …, 2021 - mdpi.com
Depression is the most prevalent psychiatric disorder in the world, affecting 4.4% of the
global population. Despite an array of treatment modalities, depressive disorders remain …

Fever of unknown origin

G Haidar, N Singh - New England Journal of Medicine, 2022 - Mass Medical Soc
Fever of Unknown Origin FUO despite a high-quality workup after a reasonable amount of
time has elapsed to rule out self-limited fevers remains a challenge. The clinician must pay …

5-Hydroxytryptophan (5-HTP): Natural occurrence, analysis, biosynthesis, biotechnology, physiology and toxicology

ME Maffei - International journal of molecular sciences, 2020 - mdpi.com
L-5-hydroxytryptophan (5-HTP) is both a drug and a natural component of some dietary
supplements. 5-HTP is produced from tryptophan by tryptophan hydroxylase (TPH), which is …

Significance of an electrochemical sensor and nanocomposites: Toward the electrocatalytic detection of neurotransmitters and their importance within the …

H Kaur, SS Siwal, RV Saini, N Singh… - ACS Nanoscience …, 2022 - ACS Publications
A prominent neurotransmitter (NT), dopamine (DA), is a chemical messenger that transmits
signals between one neuron to the next to pass on a signal to and from the central nervous …

Pharmacokinetics, pharmacodynamics and drug–drug interactions of new anti-migraine drugs—Lasmiditan, gepants, and calcitonin-gene-related peptide (CGRP) …

D Szkutnik-Fiedler - Pharmaceutics, 2020 - mdpi.com
In the last few years, there have been significant advances in migraine management and
prevention. Lasmiditan, ubrogepant, rimegepant and monoclonal antibodies (erenumab …

A review of synthetic cathinones emerging in recent years (2019–2022)

P Kuropka, M Zawadzki, P Szpot - Forensic toxicology, 2023 - Springer
Purpose The emergence of novel psychoactive substances (NPS) has been being a
continuous and evolving problem for more than a decade. Every year, dozens of new …

Serotonin syndrome: a clinical update

KC Mills - Critical care clinics, 1997 - Elsevier
Serotonin syndrome (SS) is an important drug-related complication of psychopharmacologic
therapy for major depression, bipolar affective disorder, obsessive-compulsive disorder …

[HTML][HTML] Lower urinary tract symptoms in depression: a review

DJ Anderson, A Aucoin, CR Toups… - Health psychology …, 2023 - ncbi.nlm.nih.gov
Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Serotonin in health and disease

P De Deurwaerdère, G Di Giovanni - International journal of molecular …, 2020 - mdpi.com
The International Journal of Molecular Sciences Special Issue “Serotonin in health and
diseases” covers several aspects of the multiple and still mysterious functions of serotonin (5 …

Novel rapid-acting glutamatergic modulators: targeting the synaptic plasticity in depression

YT Wang, XL Wang, ST Feng, NH Chen… - Pharmacological …, 2021 - Elsevier
Major depressive disorder (MDD) is severely prevalent, and conventional monoaminergic
antidepressants gradually exhibit low therapeutic efficiency, especially for patients with …